Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Analyzing Cell-Free DNA Seq Data from Cancer Patients to find Actionable Variants

    Webinar:
    How to Analyze Cell-Free DNA Sequencing Data from Cancer Patients to Identify Clinically Actionable Variants

    In this webinar, whole exome sequencing data of tumor tissue and cell-free DNA derived from two cancer patients will be used to demonstrate how non-invasive liquid biopsies from the blood have the potential to aid in precision medicine. Using Partek® Flow® software, a powerful and easy-to-use bioinformatics tool, we will analyze raw sequence data from individuals with metastatic sarcoma and metastatic breast cancer to identify clinically actionable variants.

    You will learn how to:
    • Align and filter whole exome sequencing data
    • Detect variants from tumor and cell-free DNA
    • Perform annotation and filtering to prioritize variants

    Live Sessions Offered:
    • September 27, 2017 at 10am SGT (Singapore)
    • September 28, 2017 at 2pm GMT (London)
    • September 28, 2017 at 2pm EDT (Boston)

    REGISTER NOW

Latest Articles

Collapse

  • seqadmin
    Essential Discoveries and Tools in Epitranscriptomics
    by seqadmin


    The field of epigenetics has traditionally concentrated more on DNA and how changes like methylation and phosphorylation of histones impact gene expression and regulation. However, our increased understanding of RNA modifications and their importance in cellular processes has led to a rise in epitranscriptomics research. “Epitranscriptomics brings together the concepts of epigenetics and gene expression,” explained Adrien Leger, PhD, Principal Research Scientist on Modified Bases...
    Yesterday, 07:01 AM
  • seqadmin
    Current Approaches to Protein Sequencing
    by seqadmin


    Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
    04-04-2024, 04:25 PM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, 04-11-2024, 12:08 PM
0 responses
39 views
0 likes
Last Post seqadmin  
Started by seqadmin, 04-10-2024, 10:19 PM
0 responses
41 views
0 likes
Last Post seqadmin  
Started by seqadmin, 04-10-2024, 09:21 AM
0 responses
35 views
0 likes
Last Post seqadmin  
Started by seqadmin, 04-04-2024, 09:00 AM
0 responses
55 views
0 likes
Last Post seqadmin  
Working...
X